Yahoo

First person in the world to get the breast cancer vaccine says it's changed her life. Here's how it works.

Jennifer Davis is the first person to receive the breast cancer vaccine as part of a clinical trial. (Photo illustration: Yahoo News; photos: Getty Images) Finding a cure for cancer has been the holy ...
News Medical

PDX engraftment predicts high recurrence and poor survival in triple-negative breast cancer

Patient-derived xenografts (PDX) may accurately predict early recurrence and survival outcomes in triple negative breast cancer (TNBC), offering a potential tool for tailoring treatment strategies to ...
Yahoo

Wash U vaccine trial shows promising data in preventing breast cancer recurrence

ST. LOUIS – A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer. Siteman Cancer Center just released the results of a clinical trial showing a ...

How to identify and treat triple-negative breast cancer — a rare but aggressive form of cancer

Triple-negative breast cancer does not respond to targeted breast cancer treatments, which limits treatment to primarily chemotherapy for now.
Los Angeles Times

Triple-Negative Breast Cancer (TNBC): Understanding Diagnosis and Treatment

Triple Negative Breast Cancer (TNBC) is one of the most aggresive types of breast cancer. It’s the kind of breast cancer that doesn’t have estrogen receptors, progesterone receptors, and human ...
Monthly Prescribing Reference

Multigene Signature Can Help Tailor Chemo for Operable Triple-Negative Breast Cancer

Improved 3-year disease-free and recurrence-free survival seen with intensive chemotherapy regimen. HealthDay News — For patients with operative triple-negative breast cancer, a multigene signature ...
Medscape

Debate Over? Data Support Adjuvant Carboplatin in Early TNBC

Adjuvant carboplatin added to standard anthracycline/taxane chemotherapy significantly improves outcomes in early ...
Fox Business

Breast cancer vaccine could prevent most aggressive form of disease from reoccurring

Anixa Biosciences CEO Dr. Amit Kumar told FOX Business that the company is working on a "game-changing vaccine" that could prevent the recurrence of the most aggressive form of breast cancer. It's ...
Cure Today

Low ctDNA Levels May Show Longer Recurrence-Free Interval in Breast Cancer

The ZEST trial, a phase 3 study on MRD-guided therapy in breast cancer, was terminated early due to low randomization rates. ctDNA was most frequently detected within six months post-treatment, ...
Nasdaq

Merck’s KEYTRUDA® (pembrolizumab) Receives Four New Approvals in Japan, Including in High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC)

KEYTRUDA in combination with chemotherapy as neoadjuvant treatment, and then continued as monotherapy as adjuvant treatment after surgery for patients with hormone receptor-negative and human ...
Morningstar

Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the first clinical study results from its Oncodetect® molecular residual disease (MRD) ...
AOL

First person in the world to get the breast cancer vaccine says it's changed her life. Here's how it works.

Finding a cure for cancer has been the holy grail in medicine for years. With the exception of the only two cancer vaccines currently available — one for HPV, strains of which can cause cancer, ...